loading page

Isolated, sudden, recoverable olfactory dysfunction: a pathognomonic sign of COVID-19
  • +2
  • Aytuğ Altundağ,
  • özlem saatci,
  • Özge Arıcı Düz,
  • Oktay Ölmüşçelik,
  • Aysegul Karaaltin
Aytuğ Altundağ
Biruni Universitesi
Author Profile
özlem saatci
Sancaktepe Sehit Prof Dr Ilhan Varank Egitim ve Arastirma Hastanesi
Author Profile
Özge Arıcı Düz
Istanbul Medipol University
Author Profile
Oktay Ölmüşçelik
Istanbul Medipol University
Author Profile
Aysegul Karaaltin
Istanbul University
Author Profile

Abstract

Objectives This study aimed to define the clinical features of anosmia, a symptom observed in patients with coronavirus disease 2019 (COVID-19). Methods The presence of olfactory symptoms, such as loss of smell, in COVID-19 patients and their relationship with the disease process were evaluated. Results A total of 217 patients with COVID-19 were evaluated, of which 135 patients were interviewed via phone calls. The patients were divided into four subgroups: group 1 had only olfactory complaints (isolated, sudden-onset loss of smell); group 2 had isolated, sudden-onset loss of smell, followed by typical COVID-19 complaints; group 3 initially had typical COVID-19 complaints, but gradually developed olfactory complaints; and group 4 had no olfactory complaints. In total, 59.3% of the patients had olfactory complaints. In groups 1–3, the odor scores after the disease were significantly lower than those before the disease; this decrease was more evident in groups 1 and 2 than in group 3 (p = 0.003, p = 0.000, and p = 0.014, respectively). Groups 1 and 2 had a greater loss of smell than group 3 (7.8 ± 2.1 in groups 1 and 2 vs. 6.2 ± 2.6 in group 3; p = 0.01). The odor scores completely returned to the pre-disease values in 51.2% of patients with olfactory dysfunction (41 patients); the mean duration of loss of smell was 7.1 ± 2.4 days. Conclusion Timely detection of anosmia is important in patients with COVID-19 in order to help control the spread of this highly contagious disease.